Figure 3
Figure 3. Cumulative incidence of t-MDS/AML in patients treated on COG therapeutic trial INT-0091, by treatment regimen.

Cumulative incidence of t-MDS/AML in patients treated on COG therapeutic trial INT-0091, by treatment regimen.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal